APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Oncology API

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oncology API Industry Growth and Trends Forecast to 2032

Report ID 174018910127 December 2025121 pages

Choose your research edition.

Industry ResearchOncology API Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Oncology API Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Oncology API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oncology API Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Oncology API Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Oncology API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oncology API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oncology API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oncology API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oncology API include Fresenius Kabi Oncology, Suanfarma, Sterling, Shivalik Rasayan, PROCOS SPA, PolyPeptide, Olon Group, Neopharma and Natco, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oncology API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oncology API market size, estimates, and forecasts are presented in terms of sales volume (K G) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oncology API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oncology API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oncology API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oncology API Market by Company

Fresenius Kabi Oncology

Suanfarma

Sterling

Shivalik Rasayan

PROCOS SPA

PolyPeptide

Olon Group

Neopharma

Natco

Kekule Pharma

Hetero

GLS Pharma

Glenmark Life Sciences

Eisai Pharmaceuticals

Dr. Reddy's

CordenPharma

Concord Biotech

Biocon

Bachem

Aspen API

Aenova

Oncology API Segment by Type

Alkylating Agents

Antimetabolites

Others

Oncology API Segment by Application

Immunotherapy

Chemotherapy

Targeted Therapy

Others

Oncology API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oncology API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oncology API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oncology API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Alkylating Agents Table 2. Major Company of Antimetabolites Table 3. Major Company of Others Table 4. Global Oncology API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Oncology API Sales by Type (2021-2026) & (K G) Table 6. Global Oncology API Sales Market Share in Volume by Type (2021-2026) Table 7. Global Oncology API Sales by Type (2021-2026) & (US$ Million) Table 8. Global Oncology API Sales Market Share in Value by Type (2021-2026) Table 9. Global Oncology API Price by Type (2021-2026) & (US$/G) Table 10. Global Oncology API Sales by Type (2027-2032) & (K G) Table 11. Global Oncology API Sales Market Share in Volume by Type (2027-2032) Table 12. Global Oncology API Sales by Type (2027-2032) & (US$ Million) Table 13. Global Oncology API Sales Market Share in Value by Type (2027-2032) Table 14. Global Oncology API Price by Type (2027-2032) & (US$/G) Table 15. North America Oncology API Sales by Type (2021-2026) & (K G) Table 16. North America Oncology API Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Oncology API Sales by Type (2021-2026) & (K G) Table 18. Europe Oncology API Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Oncology API Sales by Type (2021-2026) & (K G) Table 20. Asia-Pacific Oncology API Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Oncology API Sales by Type (2021-2026) & (K G) Table 22. Latin America Oncology API Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Oncology API Sales by Type (2021-2026) & (K G) Table 24. Middle East and Africa Oncology API Sales by Type (2021-2026) & (US$ Million) Table 25. Oncology API Industry Trends Table 26. Oncology API Industry Drivers Table 27. Oncology API Industry Opportunities and Challenges Table 28. Oncology API Industry Restraints Table 29. Global Oncology API Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Oncology API Revenue Market Share by Company (2021-2026) Table 31. Global Oncology API Sales by Company (2021-2026) & (K G) Table 32. Global Oncology API Sales Share by Company (2021-2026) Table 33. Global Oncology API Market Price by Company (2021-2026) & (US$/G) Table 34. Global Oncology API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Oncology API Major Company Production Sites and Headquarters Table 36. Global Oncology API Company, Product Type & Application Table 37. Global Oncology API Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Oncology API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Oncology API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Oncology API Sales by Region (2021-2026) & (K G) Table 42. Global Oncology API Sales Market Share in Volume by Region (2021-2026) Table 43. Global Oncology API Sales by Region (2021-2026) & (US$ Million) Table 44. Global Oncology API Sales Market Share in Value by Region (2021-2026) Table 45. Global Oncology API Sales (K G), Value (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 46. Global Oncology API Sales by Region (2027-2032) & (K G) Table 47. Global Oncology API Sales Market Share in Volume by Region (2027-2032) Table 48. Global Oncology API Sales by Region (2027-2032) & (US$ Million) Table 49. Global Oncology API Sales Market Share in Value by Region (2027-2032) Table 50. Global Oncology API Sales (K G), Value (US$ Million), Price (US$/G) and Gross Margin (2027-2032) Table 51. Global Oncology API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Oncology API Sales by Application (2021-2026) & (K G) Table 53. Global Oncology API Sales Market Share in Volume by Application (2021-2026) Table 54. Global Oncology API Sales by Application (2021-2026) & (US$ Million) Table 55. Global Oncology API Sales Market Share in Value by Application (2021-2026) Table 56. Global Oncology API Price by Application (2021-2026) & (US$/G) Table 57. Global Oncology API Sales by Application (2027-2032) & (K G) Table 58. Global Oncology API Sales Market Share in Volume by Application (2027-2032) Table 59. Global Oncology API Sales by Application (2027-2032) & (US$ Million) Table 60. Global Oncology API Sales Market Share in Value by Application (2027-2032) Table 61. Global Oncology API Price by Application (2027-2032) & (US$/G) Table 62. North America Oncology API Sales by Application (2021-2026) & (K G) Table 63. North America Oncology API Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Oncology API Sales by Application (2021-2026) & (K G) Table 65. Europe Oncology API Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Oncology API Sales by Application (2021-2026) & (K G) Table 67. Asia-Pacific Oncology API Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Oncology API Sales by Application (2021-2026) & (K G) Table 69. Latin America Oncology API Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Oncology API Sales by Application (2021-2026) & (K G) Table 71. Middle East and Africa Oncology API Sales by Application (2021-2026) & (US$ Million) Table 72. Fresenius Kabi Oncology Company Information Table 73. Fresenius Kabi Oncology Business Overview Table 74. Fresenius Kabi Oncology Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 75. Fresenius Kabi Oncology Oncology API Product Portfolio Table 76. Fresenius Kabi Oncology Recent Development Table 77. Suanfarma Company Information Table 78. Suanfarma Business Overview Table 79. Suanfarma Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 80. Suanfarma Oncology API Product Portfolio Table 81. Suanfarma Recent Development Table 82. Sterling Company Information Table 83. Sterling Business Overview Table 84. Sterling Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 85. Sterling Oncology API Product Portfolio Table 86. Sterling Recent Development Table 87. Shivalik Rasayan Company Information Table 88. Shivalik Rasayan Business Overview Table 89. Shivalik Rasayan Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 90. Shivalik Rasayan Oncology API Product Portfolio Table 91. Shivalik Rasayan Recent Development Table 92. PROCOS SPA Company Information Table 93. PROCOS SPA Business Overview Table 94. PROCOS SPA Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 95. PROCOS SPA Oncology API Product Portfolio Table 96. PROCOS SPA Recent Development Table 97. PolyPeptide Company Information Table 98. PolyPeptide Business Overview Table 99. PolyPeptide Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 100. PolyPeptide Oncology API Product Portfolio Table 101. PolyPeptide Recent Development Table 102. Olon Group Company Information Table 103. Olon Group Business Overview Table 104. Olon Group Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 105. Olon Group Oncology API Product Portfolio Table 106. Olon Group Recent Development Table 107. Neopharma Company Information Table 108. Neopharma Business Overview Table 109. Neopharma Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 110. Neopharma Oncology API Product Portfolio Table 111. Neopharma Recent Development Table 112. Natco Company Information Table 113. Natco Business Overview Table 114. Natco Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 115. Natco Oncology API Product Portfolio Table 116. Natco Recent Development Table 117. Kekule Pharma Company Information Table 118. Kekule Pharma Business Overview Table 119. Kekule Pharma Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 120. Kekule Pharma Oncology API Product Portfolio Table 121. Kekule Pharma Recent Development Table 122. Hetero Company Information Table 123. Hetero Business Overview Table 124. Hetero Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 125. Hetero Oncology API Product Portfolio Table 126. Hetero Recent Development Table 127. GLS Pharma Company Information Table 128. GLS Pharma Business Overview Table 129. GLS Pharma Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 130. GLS Pharma Oncology API Product Portfolio Table 131. GLS Pharma Recent Development Table 132. Glenmark Life Sciences Company Information Table 133. Glenmark Life Sciences Business Overview Table 134. Glenmark Life Sciences Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 135. Glenmark Life Sciences Oncology API Product Portfolio Table 136. Glenmark Life Sciences Recent Development Table 137. Eisai Pharmaceuticals Company Information Table 138. Eisai Pharmaceuticals Business Overview Table 139. Eisai Pharmaceuticals Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 140. Eisai Pharmaceuticals Oncology API Product Portfolio Table 141. Eisai Pharmaceuticals Recent Development Table 142. Dr. Reddy's Company Information Table 143. Dr. Reddy's Business Overview Table 144. Dr. Reddy's Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 145. Dr. Reddy's Oncology API Product Portfolio Table 146. Dr. Reddy's Recent Development Table 147. CordenPharma Company Information Table 148. CordenPharma Business Overview Table 149. CordenPharma Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 150. CordenPharma Oncology API Product Portfolio Table 151. CordenPharma Recent Development Table 152. Concord Biotech Company Information Table 153. Concord Biotech Business Overview Table 154. Concord Biotech Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 155. Concord Biotech Oncology API Product Portfolio Table 156. Concord Biotech Recent Development Table 157. Biocon Company Information Table 158. Biocon Business Overview Table 159. Biocon Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 160. Biocon Oncology API Product Portfolio Table 161. Biocon Recent Development Table 162. Bachem Company Information Table 163. Bachem Business Overview Table 164. Bachem Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 165. Bachem Oncology API Product Portfolio Table 166. Bachem Recent Development Table 167. Aspen API Company Information Table 168. Aspen API Business Overview Table 169. Aspen API Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 170. Aspen API Oncology API Product Portfolio Table 171. Aspen API Recent Development Table 172. Aenova Company Information Table 173. Aenova Business Overview Table 174. Aenova Oncology API Sales (K G), Revenue (US$ Million), Price (US$/G) and Gross Margin (2021-2026) Table 175. Aenova Oncology API Product Portfolio Table 176. Aenova Recent Development Table 177. North America Oncology API Market Size Growth Rate (CAGR) by Country (K G): 2021 VS 2025 VS 2032 Table 178. North America Oncology API Sales by Country (2021-2026) & (K G) Table 179. North America Oncology API Sales Market Share by Country (2021-2026) Table 180. North America Oncology API Sales Forecast by Country (2027-2032) & (K G) Table 181. North America Oncology API Sales Market Share Forecast by Country (2027-2032) Table 182. North America Oncology API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. North America Oncology API Market Size by Country (2021-2026) & (US$ Million) Table 184. North America Oncology API Market Share by Country (2021-2026) Table 185. North America Oncology API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. North America Oncology API Market Share Forecast by Country (2027-2032) Table 187. Europe Oncology API Market Size Growth Rate (CAGR) by Country (K G): 2021 VS 2025 VS 2032 Table 188. Europe Oncology API Sales by Country (2021-2026) & (K G) Table 189. Europe Oncology API Sales Market Share by Country (2021-2026) Table 190. Europe Oncology API Sales Forecast by Country (2027-2032) & (K G) Table 191. Europe Oncology API Sales Market Share Forecast by Country (2027-2032) Table 192. Europe Oncology API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Europe Oncology API Market Size by Country (2021-2026) & (US$ Million) Table 194. Europe Oncology API Market Share by Country (2021-2026) Table 195. Europe Oncology API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Europe Oncology API Market Share Forecast by Country (2027-2032) Table 197. Asia-Pacific Oncology API Market Size Growth Rate (CAGR) by Country (K G): 2021 VS 2025 VS 2032 Table 198. Asia-Pacific Oncology API Sales by Country (2021-2026) & (K G) Table 199. Asia-Pacific Oncology API Sales Market Share by Country (2021-2026) Table 200. Asia-Pacific Oncology API Sales Forecast by Country (2027-2032) & (K G) Table 201. Asia-Pacific Oncology API Sales Market Share Forecast by Country (2027-2032) Table 202. Asia-Pacific Oncology API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 203. Asia-Pacific Oncology API Market Size by Country (2021-2026) & (US$ Million) Table 204. Asia-Pacific Oncology API Market Share by Country (2021-2026) Table 205. Asia-Pacific Oncology API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 206. Asia-Pacific Oncology API Market Share Forecast by Country (2027-2032) Table 207. Latin America Oncology API Market Size Growth Rate (CAGR) by Country (K G): 2021 VS 2025 VS 2032 Table 208. Latin America Oncology API Sales by Country (2021-2026) & (K G) Table 209. Latin America Oncology API Sales Market Share by Country (2021-2026) Table 210. Latin America Oncology API Sales Forecast by Country (2027-2032) & (K G) Table 211. Latin America Oncology API Sales Market Share Forecast by Country (2027-2032) Table 212. Latin America Oncology API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 213. Latin America Oncology API Market Size by Country (2021-2026) & (US$ Million) Table 214. Latin America Oncology API Market Share by Country (2021-2026) Table 215. Latin America Oncology API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 216. Latin America Oncology API Market Share Forecast by Country (2027-2032) Table 217. Middle East and Africa Oncology API Market Size Growth Rate (CAGR) by Country (K G): 2021 VS 2025 VS 2032 Table 218. Middle East and Africa Oncology API Sales by Country (2021-2026) & (K G) Table 219. Middle East and Africa Oncology API Sales Market Share by Country (2021-2026) Table 220. Middle East and Africa Oncology API Sales Forecast by Country (2027-2032) & (K G) Table 221. Middle East and Africa Oncology API Sales Market Share Forecast by Country (2027-2032) Table 222. Middle East and Africa Oncology API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 223. Middle East and Africa Oncology API Market Size by Country (2021-2026) & (US$ Million) Table 224. Middle East and Africa Oncology API Market Share by Country (2021-2026) Table 225. Middle East and Africa Oncology API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 226. Middle East and Africa Oncology API Market Share Forecast by Country (2027-2032) Table 227. Key Raw Materials Table 228. Raw Materials Key Suppliers Table 229. Oncology API Distributors List Table 230. Oncology API Customers List Table 231. Research Programs/Design for This Report Table 232. Authors List of This Report Table 233. Secondary Sources Table 234. Primary Sources List of Figures Figure 1. Oncology API Image Figure 2. Global Oncology API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oncology API Market Size (2021-2032) & (US$ Million) Figure 4. Global Oncology API Sales (2021-2032) & (K G) Figure 5. Alkylating Agents Image Figure 6. Global Alkylating Agents Sales YoY Growth (2021-2032) & (K G) Figure 7. Antimetabolites Image Figure 8. Global Antimetabolites Sales YoY Growth (2021-2032) & (K G) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K G) Figure 11. Global Oncology API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Oncology API Market Share by Type 2025 VS 2032 Figure 13. North America Oncology API Sales Market Share in Volume by Type in 2025 Figure 14. North America Oncology API Sales Market Share in Value by Type in 2025 Figure 15. Europe Oncology API Sales Market Share in Volume by Type in 2025 Figure 16. Europe Oncology API Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Oncology API Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Oncology API Sales Market Share in Value by Type in 2025 Figure 19. Latin America Oncology API Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Oncology API Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Oncology API Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Oncology API Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Oncology API Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Immunotherapy Image Figure 26. Global Immunotherapy Sales YoY Growth (2021-2032) & (K G) Figure 27. Chemotherapy Image Figure 28. Global Chemotherapy Sales YoY Growth (2021-2032) & (K G) Figure 29. Targeted Therapy Image Figure 30. Global Targeted Therapy Sales YoY Growth (2021-2032) & (K G) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K G) Figure 33. Global Oncology API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Oncology API Market Share by Application 2025 VS 2032 Figure 35. North America Oncology API Sales Market Share in Volume by Application in 2025 Figure 36. North America Oncology API Sales Market Share in Value by Application in 2025 Figure 37. Europe Oncology API Sales Market Share in Volume by Application in 2025 Figure 38. Europe Oncology API Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Oncology API Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Oncology API Sales Market Share in Value by Application in 2025 Figure 41. Latin America Oncology API Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Oncology API Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Oncology API Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Oncology API Sales Market Share in Value by Application in 2025 Figure 45. North America Oncology API Sales by Country: 2021 VS 2025 VS 2032 (K G) Figure 46. North America Oncology API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Oncology API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Oncology API Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Oncology API Sales by Country: 2021 VS 2025 VS 2032 (K G) Figure 50. Europe Oncology API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Oncology API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Oncology API Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Oncology API Sales by Country: 2021 VS 2025 VS 2032 (K G) Figure 54. Asia-Pacific Oncology API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Oncology API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Oncology API Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Oncology API Sales by Country: 2021 VS 2025 VS 2032 (K G) Figure 58. Latin America Oncology API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Oncology API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Oncology API Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Oncology API Sales by Country: 2021 VS 2025 VS 2032 (K G) Figure 62. Middle East and Africa Oncology API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Oncology API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Oncology API Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Oncology API Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Oncology API Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Alkylating Agents
  • Antimetabolites
  • Others
Applications
  • Immunotherapy
  • Chemotherapy
  • Targeted Therapy
  • Others
Companies covered
  • Fresenius Kabi Oncology
  • Suanfarma
  • Sterling
  • Shivalik Rasayan
  • PROCOS SPA
  • PolyPeptide
  • Olon Group
  • Neopharma
  • Natco
  • Kekule Pharma
  • Hetero
  • GLS Pharma
  • Glenmark Life Sciences
  • Eisai Pharmaceuticals
  • Dr. Reddy's
  • CordenPharma
  • Concord Biotech
  • Biocon
  • Bachem
  • Aspen API
  • Aenova

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oncology API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oncology API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oncology API Market by Type
  6. 1.3.1 Alkylating Agents
  7. 1.3.2 Antimetabolites
  8. 1.3.3 Others
  9. 1.4 Global Oncology API Market Size by Type
  10. 1.4.1 Global Oncology API Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Oncology API Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Oncology API Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Oncology API Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Oncology API Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Oncology API Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Oncology API Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Oncology API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oncology API Industry Trends
  2. 2.2 Oncology API Industry Drivers
  3. 2.3 Oncology API Industry Opportunities and Challenges
  4. 2.4 Oncology API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oncology API Revenue (2021-2026)
  2. 3.2 Global Top Players by Oncology API Sales (2021-2026)
  3. 3.3 Global Top Players by Oncology API Price (2021-2026)
  4. 3.4 Global Oncology API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oncology API Major Company Production Sites & Headquarters
  6. 3.6 Global Oncology API Company, Product Type & Application
  7. 3.7 Global Oncology API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oncology API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oncology API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oncology API Tier 1, Tier 2, and Tier 3
4 Oncology API Regional Status and Outlook
  1. 4.1 Global Oncology API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oncology API Historic Market Size by Region
  3. 4.2.1 Global Oncology API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oncology API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oncology API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oncology API Forecasted Market Size by Region
  7. 4.3.1 Global Oncology API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oncology API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oncology API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oncology API by Application
  1. 5.1 Oncology API Market by Application
  2. 5.1.1 Immunotherapy
  3. 5.1.2 Chemotherapy
  4. 5.1.3 Targeted Therapy
  5. 5.1.4 Others
  6. 5.2 Global Oncology API Market Size by Application
  7. 5.2.1 Global Oncology API Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Oncology API Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Oncology API Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Oncology API Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Oncology API Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Oncology API Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Oncology API Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Oncology API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Fresenius Kabi Oncology
  2. 6.1.1 Fresenius Kabi Oncology Company Information
  3. 6.1.2 Fresenius Kabi Oncology Business Overview
  4. 6.1.3 Fresenius Kabi Oncology Oncology API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Fresenius Kabi Oncology Oncology API Product Portfolio
  6. 6.1.5 Fresenius Kabi Oncology Recent Developments
  7. 6.2 Suanfarma
  8. 6.2.1 Suanfarma Company Information
  9. 6.2.2 Suanfarma Business Overview
  10. 6.2.3 Suanfarma Oncology API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Suanfarma Oncology API Product Portfolio
  12. 6.2.5 Suanfarma Recent Developments
  13. 6.3 Sterling
  14. 6.3.1 Sterling Company Information
  15. 6.3.2 Sterling Business Overview
  16. 6.3.3 Sterling Oncology API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sterling Oncology API Product Portfolio
  18. 6.3.5 Sterling Recent Developments
  19. 6.4 Shivalik Rasayan
  20. 6.4.1 Shivalik Rasayan Company Information
  21. 6.4.2 Shivalik Rasayan Business Overview
  22. 6.4.3 Shivalik Rasayan Oncology API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shivalik Rasayan Oncology API Product Portfolio
  24. 6.4.5 Shivalik Rasayan Recent Developments
  25. 6.5 PROCOS SPA
  26. 6.5.1 PROCOS SPA Company Information
  27. 6.5.2 PROCOS SPA Business Overview
  28. 6.5.3 PROCOS SPA Oncology API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 PROCOS SPA Oncology API Product Portfolio
  30. 6.5.5 PROCOS SPA Recent Developments
  31. 6.6 PolyPeptide
  32. 6.6.1 PolyPeptide Company Information
  33. 6.6.2 PolyPeptide Business Overview
  34. 6.6.3 PolyPeptide Oncology API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 PolyPeptide Oncology API Product Portfolio
  36. 6.6.5 PolyPeptide Recent Developments
  37. 6.7 Olon Group
  38. 6.7.1 Olon Group Company Information
  39. 6.7.2 Olon Group Business Overview
  40. 6.7.3 Olon Group Oncology API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Olon Group Oncology API Product Portfolio
  42. 6.7.5 Olon Group Recent Developments
  43. 6.8 Neopharma
  44. 6.8.1 Neopharma Company Information
  45. 6.8.2 Neopharma Business Overview
  46. 6.8.3 Neopharma Oncology API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Neopharma Oncology API Product Portfolio
  48. 6.8.5 Neopharma Recent Developments
  49. 6.9 Natco
  50. 6.9.1 Natco Company Information
  51. 6.9.2 Natco Business Overview
  52. 6.9.3 Natco Oncology API Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Natco Oncology API Product Portfolio
  54. 6.9.5 Natco Recent Developments
  55. 6.10 Kekule Pharma
  56. 6.10.1 Kekule Pharma Company Information
  57. 6.10.2 Kekule Pharma Business Overview
  58. 6.10.3 Kekule Pharma Oncology API Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Kekule Pharma Oncology API Product Portfolio
  60. 6.10.5 Kekule Pharma Recent Developments
  61. 6.11 Hetero
  62. 6.11.1 Hetero Company Information
  63. 6.11.2 Hetero Business Overview
  64. 6.11.3 Hetero Oncology API Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hetero Oncology API Product Portfolio
  66. 6.11.5 Hetero Recent Developments
  67. 6.12 GLS Pharma
  68. 6.12.1 GLS Pharma Company Information
  69. 6.12.2 GLS Pharma Business Overview
  70. 6.12.3 GLS Pharma Oncology API Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 GLS Pharma Oncology API Product Portfolio
  72. 6.12.5 GLS Pharma Recent Developments
  73. 6.13 Glenmark Life Sciences
  74. 6.13.1 Glenmark Life Sciences Company Information
  75. 6.13.2 Glenmark Life Sciences Business Overview
  76. 6.13.3 Glenmark Life Sciences Oncology API Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Glenmark Life Sciences Oncology API Product Portfolio
  78. 6.13.5 Glenmark Life Sciences Recent Developments
  79. 6.14 Eisai Pharmaceuticals
  80. 6.14.1 Eisai Pharmaceuticals Company Information
  81. 6.14.2 Eisai Pharmaceuticals Business Overview
  82. 6.14.3 Eisai Pharmaceuticals Oncology API Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Eisai Pharmaceuticals Oncology API Product Portfolio
  84. 6.14.5 Eisai Pharmaceuticals Recent Developments
  85. 6.15 Dr. Reddy's
  86. 6.15.1 Dr. Reddy's Company Information
  87. 6.15.2 Dr. Reddy's Business Overview
  88. 6.15.3 Dr. Reddy's Oncology API Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Dr. Reddy's Oncology API Product Portfolio
  90. 6.15.5 Dr. Reddy's Recent Developments
  91. 6.16 CordenPharma
  92. 6.16.1 CordenPharma Company Information
  93. 6.16.2 CordenPharma Business Overview
  94. 6.16.3 CordenPharma Oncology API Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 CordenPharma Oncology API Product Portfolio
  96. 6.16.5 CordenPharma Recent Developments
  97. 6.17 Concord Biotech
  98. 6.17.1 Concord Biotech Company Information
  99. 6.17.2 Concord Biotech Business Overview
  100. 6.17.3 Concord Biotech Oncology API Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Concord Biotech Oncology API Product Portfolio
  102. 6.17.5 Concord Biotech Recent Developments
  103. 6.18 Biocon
  104. 6.18.1 Biocon Company Information
  105. 6.18.2 Biocon Business Overview
  106. 6.18.3 Biocon Oncology API Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Biocon Oncology API Product Portfolio
  108. 6.18.5 Biocon Recent Developments
  109. 6.19 Bachem
  110. 6.19.1 Bachem Company Information
  111. 6.19.2 Bachem Business Overview
  112. 6.19.3 Bachem Oncology API Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Bachem Oncology API Product Portfolio
  114. 6.19.5 Bachem Recent Developments
  115. 6.20 Aspen API
  116. 6.20.1 Aspen API Company Information
  117. 6.20.2 Aspen API Business Overview
  118. 6.20.3 Aspen API Oncology API Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Aspen API Oncology API Product Portfolio
  120. 6.20.5 Aspen API Recent Developments
  121. 6.21 Aenova
  122. 6.21.1 Aenova Company Information
  123. 6.21.2 Aenova Business Overview
  124. 6.21.3 Aenova Oncology API Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Aenova Oncology API Product Portfolio
  126. 6.21.5 Aenova Recent Developments
7 North America by Country
  1. 7.1 North America Oncology API Sales by Country
  2. 7.1.1 North America Oncology API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oncology API Sales by Country (2021-2026)
  4. 7.1.3 North America Oncology API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oncology API Market Size by Country
  6. 7.2.1 North America Oncology API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oncology API Market Size by Country (2021-2026)
  8. 7.2.3 North America Oncology API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oncology API Sales by Country
  2. 8.1.1 Europe Oncology API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oncology API Sales by Country (2021-2026)
  4. 8.1.3 Europe Oncology API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oncology API Market Size by Country
  6. 8.2.1 Europe Oncology API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oncology API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oncology API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oncology API Sales by Country
  2. 9.1.1 Asia-Pacific Oncology API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oncology API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oncology API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oncology API Market Size by Country
  6. 9.2.1 Asia-Pacific Oncology API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oncology API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oncology API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oncology API Sales by Country
  2. 10.1.1 South America Oncology API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oncology API Sales by Country (2021-2026)
  4. 10.1.3 South America Oncology API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oncology API Market Size by Country
  6. 10.2.1 South America Oncology API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oncology API Market Size by Country (2021-2026)
  8. 10.2.3 South America Oncology API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oncology API Sales by Country
  2. 11.1.1 Middle East and Africa Oncology API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oncology API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oncology API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oncology API Market Size by Country
  6. 11.2.1 Middle East and Africa Oncology API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oncology API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oncology API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oncology API Value Chain Analysis
  2. 12.1.1 Oncology API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oncology API Production Mode & Process
  7. 12.2 Oncology API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oncology API Distributors
  10. 12.2.3 Oncology API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst